Related Experiment Video
Updated: Apr 29, 2026

08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
7.3K
How is your biobank handling disaster recovery efforts?
Biopreservation and Biobanking
|May 22, 2014
Summary
Biobanks face increasing disaster risks, from natural events to equipment failure. This article gathers expert insights on biobank disaster preparedness and recovery strategies to ensure sample integrity.
Area of Science:
- Biopreservation
- Biobanking
- Disaster Risk Management
Background:
- Biobanks are increasingly vulnerable to natural disasters (e.g., superstorms, earthquakes) and man-made threats (e.g., freezer malfunctions, theft).
- Ensuring the continuity of biobanking operations is critical for research and public health.
Purpose of the Study:
- To gather and present expert perspectives on biobank disaster recovery strategies.
- To inform the biobanking community on effective disaster preparedness and response.
Main Methods:
- A community of experts in biopreservation and biobanking was surveyed.
- Responses regarding disaster recovery efforts were collected and compiled.
Main Results:
- Expert responses highlight diverse approaches to biobank disaster recovery.
- The article compiles practical insights into managing and recovering from biobanking-specific disasters.
Conclusions:
- Proactive disaster planning and robust recovery strategies are essential for biobank resilience.
- Sharing expert knowledge is crucial for advancing biobank security and sample preservation.
Related Concept Videos
Bioequivalence studies: Biowaivers
430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430
Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369

